Medifast, Inc. (NYSE:MED) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET

Company Participants

Steven Zenker - Vice President of Investor Relations

Dan Chard - Chairman and Chief Executive Officer

Jim Maloney - Chief Financial Officer

Conference Call Participants

Linda Bolton Weiser - D.A. Davidson

Jim Salera - Stephens Inc.

Doug Lane - Water Tower Research

Operator

Greetings. Welcome to the Medifast Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.

I'll now turn the conference over to your host, Steven Zenker, Vice President of Investor Relations. You may begin.

Steven Zenker

Good afternoon, and welcome to Medifast third quarter 2023 earnings conference call.

On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.

By now, everyone should have access to the earnings release for the quarter ended September 30, 2023, that went out this afternoon at approximately 4:05 PM Eastern Time. If you have not received the release, it is available on the Investor Relations portion of Medifast's website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website.

Before we begin, we would like to remind everyone that today's prepared remarks contain forward-looking statements and management may make additional forward-looking statements in response to your questions. The words believe, expect, anticipate and other similar expressions generally identify forward-looking statements. These statements do not guarantee future performance and, therefore, undue reliance should not be placed on them. Actual results could differ materially from those projected in any forward-looking statements.

All of the forward-looking statements contained herein speak only as of the date of this call. Metifast assumes no obligation to update any forward-looking statements that may be made in today's release or call.

And with that, I would like to turn the call over to Medifast's Chairman and Chief Executive Officer, Dan Chard.

Dan Chard

Thanks, Steve, and thanks to all of you for joining us on the call.

With me today is Jim Maloney, Medifast's Chief Financial Officer.

I'll take a few minutes to share some insights from Medifast's journey over the last 12 months and then provide you with some context for where we're taking the business. I'll then turn the call to Jim, who will take you through Q3 financials.